APO Research
Talk to an analyst

APO RESEARCH · REPORT

Codeine Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Codeine Drug Market Outlook and Growth Opportunities 2026

2 January 2026198 pages

Choose your research edition.

Industry ResearchCodeine Drug Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Drug Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Codeine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Codeine Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Codeine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Codeine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Codeine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Codeine Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Codeine Drug market include Apotex, Aristo Pharma GmbH, Cipla, Hikma, Laboratoire Riva, Lannett Company, Mallinckrodt, Medreich and Pharmaceutical Associates, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Codeine Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Codeine Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Codeine Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Codeine Drug market.

Codeine Drug Segment by Company

Apotex

Aristo Pharma GmbH

Cipla

Hikma

Laboratoire Riva

Lannett Company

Mallinckrodt

Medreich

Pharmaceutical Associates

Sanofi Aventis

Taiji

Viatris

Novartis

Johnson & Johnson

TEVA

Codeine Drug Segment by Type

Single-ingredient Codeine

Multi-ingredient Medications Codeine

Codeine Drug Segment by Application

Narcotic Analgesic

Antitussive

Others

Codeine Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Codeine Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Codeine Drug key companies, revenue, market share, and recent developments.

3. To split the Codeine Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Codeine Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Codeine Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Codeine Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Codeine Drug industry.

Chapter 3: Detailed analysis of Codeine Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Codeine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Codeine Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Codeine Drug Industry Trends Table 2. Codeine Drug Industry Drivers Table 3. Codeine Drug Industry Opportunities and Challenges Table 4. Codeine Drug Industry Restraints Table 5. Global Codeine Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Codeine Drug Revenue Share by Company (2021-2026) Table 7. Global Codeine Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Codeine Drug Key Company Manufacturing Base & Headquarters Table 9. Global Codeine Drug Company, Product Type & Application Table 10. Global Codeine Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Codeine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single-ingredient Codeine Table 15. Significant Companies of Multi-ingredient Medications Codeine Table 16. Global Codeine Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Codeine Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Codeine Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Codeine Drug Sales Value Share by Type (2021-2026) Table 20. Global Codeine Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Narcotic Analgesic Table 22. Significant Companies of Antitussive Table 23. Significant Companies of Others Table 24. Global Codeine Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Codeine Drug Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Codeine Drug Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Codeine Drug Sales Value Share by Application (2021-2026) Table 28. Global Codeine Drug Sales Value Share by Application (2027-2032) Table 29. Global Codeine Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Codeine Drug Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Codeine Drug Sales Value Share by Region (2021-2026) Table 32. Global Codeine Drug Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Codeine Drug Sales Value Share by Region (2027-2032) Table 34. Global Codeine Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Codeine Drug Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Codeine Drug Sales Value Market Share by Country (2021-2026) Table 37. Global Codeine Drug Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Codeine Drug Sales Value Market Share by Country (2027-2032) Table 39. Apotex Company Information Table 40. Apotex Business Overview Table 41. Apotex Codeine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Apotex Codeine Drug Product Portfolio Table 43. Apotex Recent Development Table 44. Aristo Pharma GmbH Company Information Table 45. Aristo Pharma GmbH Business Overview Table 46. Aristo Pharma GmbH Codeine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Aristo Pharma GmbH Codeine Drug Product Portfolio Table 48. Aristo Pharma GmbH Recent Development Table 49. Cipla Company Information Table 50. Cipla Business Overview Table 51. Cipla Codeine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Cipla Codeine Drug Product Portfolio Table 53. Cipla Recent Development Table 54. Hikma Company Information Table 55. Hikma Business Overview Table 56. Hikma Codeine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Hikma Codeine Drug Product Portfolio Table 58. Hikma Recent Development Table 59. Laboratoire Riva Company Information Table 60. Laboratoire Riva Business Overview Table 61. Laboratoire Riva Codeine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Laboratoire Riva Codeine Drug Product Portfolio Table 63. Laboratoire Riva Recent Development Table 64. Lannett Company Company Information Table 65. Lannett Company Business Overview Table 66. Lannett Company Codeine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Lannett Company Codeine Drug Product Portfolio Table 68. Lannett Company Recent Development Table 69. Mallinckrodt Company Information Table 70. Mallinckrodt Business Overview Table 71. Mallinckrodt Codeine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Mallinckrodt Codeine Drug Product Portfolio Table 73. Mallinckrodt Recent Development Table 74. Medreich Company Information Table 75. Medreich Business Overview Table 76. Medreich Codeine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Medreich Codeine Drug Product Portfolio Table 78. Medreich Recent Development Table 79. Pharmaceutical Associates Company Information Table 80. Pharmaceutical Associates Business Overview Table 81. Pharmaceutical Associates Codeine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pharmaceutical Associates Codeine Drug Product Portfolio Table 83. Pharmaceutical Associates Recent Development Table 84. Sanofi Aventis Company Information Table 85. Sanofi Aventis Business Overview Table 86. Sanofi Aventis Codeine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sanofi Aventis Codeine Drug Product Portfolio Table 88. Sanofi Aventis Recent Development Table 89. Taiji Company Information Table 90. Taiji Business Overview Table 91. Taiji Codeine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Taiji Codeine Drug Product Portfolio Table 93. Taiji Recent Development Table 94. Viatris Company Information Table 95. Viatris Business Overview Table 96. Viatris Codeine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Viatris Codeine Drug Product Portfolio Table 98. Viatris Recent Development Table 99. Novartis Company Information Table 100. Novartis Business Overview Table 101. Novartis Codeine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Novartis Codeine Drug Product Portfolio Table 103. Novartis Recent Development Table 104. Johnson & Johnson Company Information Table 105. Johnson & Johnson Business Overview Table 106. Johnson & Johnson Codeine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Johnson & Johnson Codeine Drug Product Portfolio Table 108. Johnson & Johnson Recent Development Table 109. TEVA Company Information Table 110. TEVA Business Overview Table 111. TEVA Codeine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. TEVA Codeine Drug Product Portfolio Table 113. TEVA Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Codeine Drug Product Image Figure 2. Global Codeine Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Codeine Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single-ingredient Codeine Image Figure 8. Multi-ingredient Medications Codeine Image Figure 9. Global Codeine Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Codeine Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Codeine Drug Sales Value Share by Type (2021-2032) Figure 12. Narcotic Analgesic Image Figure 13. Antitussive Image Figure 14. Others Image Figure 15. Global Codeine Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Codeine Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Codeine Drug Sales Value Share by Application (2021-2032) Figure 18. Global Codeine Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Codeine Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Codeine Drug Sales Value (2021-2032) & (US$ Million) Figure 21. North America Codeine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Codeine Drug Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Codeine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Codeine Drug Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Codeine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Codeine Drug Sales Value (2021-2032) & (US$ Million) Figure 27. South America Codeine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Codeine Drug Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Codeine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Codeine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Codeine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Codeine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient Codeine
  • Multi-ingredient Medications Codeine
Applications
  • Narcotic Analgesic
  • Antitussive
  • Others
Companies covered
  • Apotex
  • Aristo Pharma GmbH
  • Cipla
  • Hikma
  • Laboratoire Riva
  • Lannett Company
  • Mallinckrodt
  • Medreich
  • Pharmaceutical Associates
  • Sanofi Aventis
  • Taiji
  • Viatris
  • Novartis
  • Johnson & Johnson
  • TEVA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Codeine Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Codeine Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Codeine Drug Market Dynamics
  1. 2.1 Codeine Drug Industry Trends
  2. 2.2 Codeine Drug Industry Drivers
  3. 2.3 Codeine Drug Industry Opportunities and Challenges
  4. 2.4 Codeine Drug Industry Restraints
3 Codeine Drug Market by Company
  1. 3.1 Global Codeine Drug Company Revenue Ranking in 2025
  2. 3.2 Global Codeine Drug Revenue by Company (2021-2026)
  3. 3.3 Global Codeine Drug Company Ranking (2024-2026)
  4. 3.4 Global Codeine Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Codeine Drug Company Product Type and Application
  6. 3.6 Global Codeine Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Codeine Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Codeine Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Codeine Drug Market by Type
  1. 4.1 Codeine Drug Type Introduction
  2. 4.1.1 Single-ingredient Codeine
  3. 4.1.2 Multi-ingredient Medications Codeine
  4. 4.2 Global Codeine Drug Sales Value by Type
  5. 4.2.1 Global Codeine Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Codeine Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global Codeine Drug Sales Value Share by Type (2021-2032)
5 Codeine Drug Market by Application
  1. 5.1 Codeine Drug Application Introduction
  2. 5.1.1 Narcotic Analgesic
  3. 5.1.2 Antitussive
  4. 5.1.3 Others
  5. 5.2 Global Codeine Drug Sales Value by Application
  6. 5.2.1 Global Codeine Drug Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Codeine Drug Sales Value by Application (2021-2032)
  8. 5.2.3 Global Codeine Drug Sales Value Share by Application (2021-2032)
6 Codeine Drug Regional Value Analysis
  1. 6.1 Global Codeine Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Codeine Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Codeine Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Codeine Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Codeine Drug Sales Value (2021-2032)
  7. 6.3.2 North America Codeine Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Codeine Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Codeine Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Codeine Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Codeine Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Codeine Drug Sales Value (2021-2032)
  16. 6.6.2 South America Codeine Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Codeine Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Codeine Drug Sales Value Share by Country, 2025 VS 2032
7 Codeine Drug Country-level Value Analysis
  1. 7.1 Global Codeine Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Codeine Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Codeine Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Codeine Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Codeine Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Codeine Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Codeine Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Codeine Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Codeine Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Codeine Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Codeine Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Codeine Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Codeine Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Codeine Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Codeine Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Codeine Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Codeine Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Codeine Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Codeine Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Codeine Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Codeine Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Codeine Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Codeine Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Codeine Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Codeine Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Codeine Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Codeine Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Codeine Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Codeine Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Codeine Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Codeine Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Codeine Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Codeine Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Codeine Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Codeine Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Codeine Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Codeine Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Codeine Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Codeine Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Codeine Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Codeine Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Codeine Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Codeine Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Codeine Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Codeine Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Codeine Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Codeine Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Codeine Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Codeine Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Codeine Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Codeine Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Codeine Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Codeine Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Codeine Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Codeine Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Codeine Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Codeine Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Codeine Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Codeine Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Codeine Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Codeine Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Codeine Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Codeine Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Codeine Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Codeine Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Codeine Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Codeine Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Codeine Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Codeine Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Codeine Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Codeine Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Codeine Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Codeine Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Codeine Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Codeine Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Codeine Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Codeine Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Codeine Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Codeine Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Codeine Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Codeine Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Codeine Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Codeine Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Codeine Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Codeine Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Codeine Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Codeine Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Codeine Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Apotex
  2. 8.1.1 Apotex Company Information
  3. 8.1.2 Apotex Business Overview
  4. 8.1.3 Apotex Codeine Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Apotex Codeine Drug Product Portfolio
  6. 8.1.5 Apotex Recent Developments
  7. 8.2 Aristo Pharma GmbH
  8. 8.2.1 Aristo Pharma GmbH Company Information
  9. 8.2.2 Aristo Pharma GmbH Business Overview
  10. 8.2.3 Aristo Pharma GmbH Codeine Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aristo Pharma GmbH Codeine Drug Product Portfolio
  12. 8.2.5 Aristo Pharma GmbH Recent Developments
  13. 8.3 Cipla
  14. 8.3.1 Cipla Company Information
  15. 8.3.2 Cipla Business Overview
  16. 8.3.3 Cipla Codeine Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cipla Codeine Drug Product Portfolio
  18. 8.3.5 Cipla Recent Developments
  19. 8.4 Hikma
  20. 8.4.1 Hikma Company Information
  21. 8.4.2 Hikma Business Overview
  22. 8.4.3 Hikma Codeine Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hikma Codeine Drug Product Portfolio
  24. 8.4.5 Hikma Recent Developments
  25. 8.5 Laboratoire Riva
  26. 8.5.1 Laboratoire Riva Company Information
  27. 8.5.2 Laboratoire Riva Business Overview
  28. 8.5.3 Laboratoire Riva Codeine Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Laboratoire Riva Codeine Drug Product Portfolio
  30. 8.5.5 Laboratoire Riva Recent Developments
  31. 8.6 Lannett Company
  32. 8.6.1 Lannett Company Company Information
  33. 8.6.2 Lannett Company Business Overview
  34. 8.6.3 Lannett Company Codeine Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lannett Company Codeine Drug Product Portfolio
  36. 8.6.5 Lannett Company Recent Developments
  37. 8.7 Mallinckrodt
  38. 8.7.1 Mallinckrodt Company Information
  39. 8.7.2 Mallinckrodt Business Overview
  40. 8.7.3 Mallinckrodt Codeine Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mallinckrodt Codeine Drug Product Portfolio
  42. 8.7.5 Mallinckrodt Recent Developments
  43. 8.8 Medreich
  44. 8.8.1 Medreich Company Information
  45. 8.8.2 Medreich Business Overview
  46. 8.8.3 Medreich Codeine Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medreich Codeine Drug Product Portfolio
  48. 8.8.5 Medreich Recent Developments
  49. 8.9 Pharmaceutical Associates
  50. 8.9.1 Pharmaceutical Associates Company Information
  51. 8.9.2 Pharmaceutical Associates Business Overview
  52. 8.9.3 Pharmaceutical Associates Codeine Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pharmaceutical Associates Codeine Drug Product Portfolio
  54. 8.9.5 Pharmaceutical Associates Recent Developments
  55. 8.10 Sanofi Aventis
  56. 8.10.1 Sanofi Aventis Company Information
  57. 8.10.2 Sanofi Aventis Business Overview
  58. 8.10.3 Sanofi Aventis Codeine Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Aventis Codeine Drug Product Portfolio
  60. 8.10.5 Sanofi Aventis Recent Developments
  61. 8.11 Taiji
  62. 8.11.1 Taiji Company Information
  63. 8.11.2 Taiji Business Overview
  64. 8.11.3 Taiji Codeine Drug Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Taiji Codeine Drug Product Portfolio
  66. 8.11.5 Taiji Recent Developments
  67. 8.12 Viatris
  68. 8.12.1 Viatris Company Information
  69. 8.12.2 Viatris Business Overview
  70. 8.12.3 Viatris Codeine Drug Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Viatris Codeine Drug Product Portfolio
  72. 8.12.5 Viatris Recent Developments
  73. 8.13 Novartis
  74. 8.13.1 Novartis Company Information
  75. 8.13.2 Novartis Business Overview
  76. 8.13.3 Novartis Codeine Drug Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Novartis Codeine Drug Product Portfolio
  78. 8.13.5 Novartis Recent Developments
  79. 8.14 Johnson & Johnson
  80. 8.14.1 Johnson & Johnson Company Information
  81. 8.14.2 Johnson & Johnson Business Overview
  82. 8.14.3 Johnson & Johnson Codeine Drug Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Johnson & Johnson Codeine Drug Product Portfolio
  84. 8.14.5 Johnson & Johnson Recent Developments
  85. 8.15 TEVA
  86. 8.15.1 TEVA Company Information
  87. 8.15.2 TEVA Business Overview
  88. 8.15.3 TEVA Codeine Drug Revenue and Gross Margin (2021-2026)
  89. 8.15.4 TEVA Codeine Drug Product Portfolio
  90. 8.15.5 TEVA Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst